Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Debt Ratio (2019 - 2021)

VYNE Therapeutics' Debt Ratio history spans 3 years, with the latest figure at 0.25 for Q2 2021.

  • For Q2 2021, Debt Ratio fell 0.98% year-over-year to 0.25; the TTM value through Jun 2021 reached 0.25, down 0.98%, while the annual FY2020 figure was 0.35, 12.24% down from the prior year.
  • Debt Ratio reached 0.25 in Q2 2021 per VYNE's latest filing, up from 0.22 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.4 in Q4 2019 to a low of 0.22 in Q1 2021.
  • Average Debt Ratio over 3 years is 0.3, with a median of 0.31 recorded in 2020.
  • The largest YoY upside for Debt Ratio was 0.98% in 2021 against a maximum downside of 31.73% in 2021.
  • A 3-year view of Debt Ratio shows it stood at 0.4 in 2019, then dropped by 12.24% to 0.35 in 2020, then dropped by 29.61% to 0.25 in 2021.
  • Per Business Quant, the three most recent readings for VYNE's Debt Ratio are 0.25 (Q2 2021), 0.22 (Q1 2021), and 0.35 (Q4 2020).